Advanced molecular cytogenetics in human and mouse

Expert Review of Molecular Diagnostics

Volumn 4, Issue 5, 2004, Pages 663-676

  Dorritie, Kathleen ^b   Montagna, Cristina ^a   Difilippantonio, Michael J ^a   Ried, Thomas ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Array CGH; Comparative cytogenetics; Comparative genomics; Cytogenetic; DOP PCR; Fluorescent in situ hybridization; Fluorochromes; Hybridization; M FISH; Microarrays; Mouse models; Multiplex FISH; Spectral karyotyping

Indexed keywords

DNA; TRASTUZUMAB;

ANEUPLOIDY; CELL NUCLEUS; CELL TYPE; CHROMOSOME ABERRATION; CHROMOSOME REARRANGEMENT; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOGENETICS; EARLY DIAGNOSIS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE TARGETING; HUMAN; KARYOTYPING; MOLECULAR DYNAMICS; MOUSE; MULTIPLEX FLUORESCENCE IN SITU HYBRIDIZATION; NONHUMAN; PRECANCER; RELIABILITY; REVIEW; TREATMENT PLANNING; TUMOR CLASSIFICATION;

ANIMALS; CHROMOSOME ABERRATIONS; CYTOGENETICS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; METAPHASE; MICE; NEOPLASMS; NUCLEIC ACID HYBRIDIZATION; SPECTRAL KARYOTYPING;

EID: 4544247507     PISSN: 14737159     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737159.4.5.663     Document Type: Review

References (162)

1. Mitelman F. Catalog of Chromosome Aberrations in Cancer Wiley-Niss, NY, USA (1994). Comprehensive list of cancer cases and their respective karyotypes with details on breakpoints, chromosome gains/losses and resulting fusion genes.
2. Atlas Genet. Cytogenet. Oncol. Haematol. Online source of cytogenetic information as well as topical reviews on various aspects related to tumor analysis and terminology.
3. Caspersson T, Zech L, Johansson C. Differential binding of alkylating fluorochromes in human chromosomes. Exp. Cell. Res. 60(3), 315-319 (1970).
4. Sumner AT, Evans HJ, Buckland RA. New technique for distinguishing between human chromosomes. Nature New Biol. 232(27), 31-32 (1971).
5. Seabright M. A rapid banding technique for human chromosomes. Lancet 2(7731), 971-972 (1971).
6. Langer-Safer PR, Levine M, Ward DC. Immunological method for mapping genes on Drosophila polytene chromosomes. Proc. Natl Acad.Sci. USA 79(14), 4381-4385 (1982).
7. Kallioniemi OP, Kallioniemi A, Sudar D et al. Comparative genomic hybridization: a rapid new method for detecting and mapping DNA amplification in tumors. Sem. Cancer Biol. 4, 41-46 (1993).
8. Liyanage M, Coleman A, du Manoir S et al.. Multicolor spectral karyotyping of mouse chromosomes. Nature Genet. 14(3), 312-315 (1996). First report of spectral karyotyping used for karyotype analysis of mouse chromosomes.
9. Schröck E, du Manoir S, Veldman T et al. Multicolor spectral karyotyping of human chromosomes. Science 273(5274), 494-497 (1996). First paper describing in detail the technique of spectral karyotyping.
10. Speicher MR, Ballard SG, Ward DC. Karyotyping human chromosomes by combinatorial multi-fluor FISH. Nature Genet. 12(4), 368-375 (1996). First paper describing the use of multifluor fluorescence in situ hybridization.
11. Popp S, Jauch A, Schindler D et al. Identification of a small, unbalanced translocation by multicolor fluorescence in situ hybridization. Hum. Genet. 92, 527-532 (1993).
12. Cremer T, Landegent JE, Bruckner A et al. Detection of chromosome aberrations in the human interphase nucleus by visualization of specific target DNAs with radioactive and nonradioactive in situ hybridization techniques: diagnosis of trisomy 18 with probe L1.84. Hum. Genet. 74, 346-352 (1986).
13. Heselmeyer-Haddad K, Janz V, Castle PE et al. Detection of genomic amplification of the human telomerase gene (TERC) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasia. Am. J. Pathol. 163(4), 1405-1416 (2003).
14. Forozan F, Karhu R, Kononen J, Kallioniemi A, Kallioniemi OP. Genome screening by comparative genomic hybridization. Trends Genet. 13(10), 405-409 (1997).
15. Ried T, Heselmeyer-Haddad K, Blegen H, Schrock E, Auer G. Genomic changes defining the genesis, progression, and malignancy potential in solid human tumors: a phenotype/genotype correlation. Genes Chromosomes Cancer 25(3), 195-204 (1999).
16. Knutsen T, Ried T. SKY: a comprehensive diagnostic and research tool A review of the first 300 published cases. J. Assoc. Genet. Technol. 26(1), 3-15 (2000).
17. Schrock E, Padilla-Nash H. Spectral karyotyping and multicolor fluorescence in situ hybridization reveal new tumor-specific chromosomal aberrations. Semin. Hematol 37(4), 334-347 (2000).
18. Hilgenfeld E, Montagna C, Padilla-Nash H et al. Spectral karyotyping in cancer cytogenetics. Methods Mol. Med. 68, 29-44 (2002).
19. Lansdorp PM, Verwoerd NP, van de Rijke FM et al. Heterogeneity in telomere length of human chromosomes. Hum. Mol. Genet. 5(5), 685-691 (1996).
20. Raap AK, van de Corput MPC, Vervenne RAW et al. Ultra-sensitive FISH using peroxidase-mediated deposition of biotin- or fluorochrome tyramides. Hum. Mol. Genet. 4, 529-534 (1995).
21. van Gijlswijk RPM, Wiegant J, Raap AK, Tanke HJ. Improved localization of fluorescent tyramides for fluorescence in situ hybridization using dextran sulfate and potyvinyl alcohol. J. Histochem. Cytochem. 44, 389-392 (1996).
22. van Gijlswijk RPM, Zijlmans HJMAA, Wiegant J et al. Fluorochrome-labeled tyramides: use in immunocytochemistry and fluorescence in situ hybridization. J. Histochem. Cytochem. 45, 375-382 (1997).
23. Schrimi LM, Padilla-Nash HM, Column A et al. Tyramide signal amplification (TSA)-FISH applied to mapping PCR-labeled probes less than 1 kb in size. Biotechniques 27(3), 608-613 (1999).
24. Baner J, Nilsson M, Mendel-Hartvig M, Landegren U. Signal amplification of padlock probes by rolling circle replication. Nucleic Acids Res. 26(22), 5073-5078 (1998).
25. Zhang DY, Brandwein M, Hsuih TC, Li H. Amplification of target-specific, ligation-dependent circular probe. Gene 211 (2), 277-285 (1998).
26. Lizardi PM, Huang X, Zhu Z et al. Mutation detection and single-molecule counting using isothermal rolling-circle amplification. Nature Genet. 19(3), 225-232 (1998).
27. Rudkin GT, Stollar BD. High resolution detection of DNA. RNA hybrids in situ by indirect immunofluorescence. Nature 265, 472-473 (1977).
28. Manuelidis L, Langer-Safer PR, Ward DC. High-resolution mapping of satellite DNA using biotin-labeled DNA probes. J. Cell. Biol. 95(2 Pt 1), 619-625 (1982). First reported use of nucleosides directly conjugated to biotin as in vitro substrates for DNA polymerase during the labeling of a DNA probe for FISH.
29. Kallioniemi A, Kallioniemi OP, Sudar D et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258, 818-821 (1992). First report describing the details of comparative genomic hybridization for the identification of chromosome imbalances.
30. Telenius H, Carter NP, Bebb CE et al. Degenerate oligonucleotide-primed PCR (DOP-PCR): general amplification of target DNA by a single degenerate primer. Genomics 13, 718-725 (1992). Describes the methodology for the PCR amplification and labeling of flow sorted chromosomes for use as painting probes.
31. Ried T, Schrock E, Ning Y, Wienberg J. Chromosome painting: a useful art. Hum. Mol. Genet. 7(10), 1619-1626 (1998).
32. Guan XY, Zhang H, Bittner M et al. Chromosome arm painting probes. Nature Genet. 12, 10-11 (1996).
33. Guan XY, Trent JM, Meltzer PS. Generation of band-specific painting probes from a single microdissected chromosome. Hum. Mol. Genet. 2, 1117-1121 (1993).
34. Kunkel LM, Lalande M, Monaco AP et al. Construction of a human X-chromosome-enriched phage library which facilitates analysis of specific loci. Gene 33(3), 251-258 (1985). First reported construction of a single chromosome library. For many years, these libraries served as the source for generating chromosome-specific painting probes.
35. Button L, Mohandas TK, Magenis RE et al. A highly polymorphic locus on chromosome 16q revealed by a probe from a chromosome-specific cosmid library. Hum. Genet. 74(4), 425-431 (1986).
36. Janssen JW, Collard JG, Tulp A et al. Construction and analysis of an EMBL-3 phage library containing partially digested human chromosome 21-specific DNA inserts (15-20 kb). Cytometry 7(5), 411-417 (1986).
37. Harris P, Lalande M, Stroh H et al. Construction of a chromosome 16-enriched phage library and characterization of several DNA segments from 16p. Hum. Genet. 77(2), 95-103 (1987).
38. Atchison LM, Naylor SL, Freed JJ, ODITUS RL. Regional mapping of unique DNA sequences from human chromosome 3 derived from a flow-sorted chromosome library. Cytogenet. Cell Genet. 48(3), 156-159 (1988).
39. Buiting K, Passarge E, Horsthemke B. Construction of a chromosome 15-specific linking library and identification of potential gene sequences. Genomics 3(2), 143-149 (1988).
40. Pinkel D, Landegent J, Collins C et al. Fluorescence in situ hybridization with human chromosome specific libraries: detection of trisomy 21 and translocation of chromosome 4. Proc. Natl Acad. Sci. USA 85,9138-9142 (1988).
41. Cremer T, Lichter P, Borden J, Ward DC, Mannuelidis L. Detection of chromosome aberrations in metaphase and interphase tumor cells by in situ hybridization using chromosome-specific library probes. Hum. Genet. 80, 235-246 (1988).
42. Lichter P, Ledbetter SA, Ledbetter DH, Ward DC. Fluorescence in situ hybridization with Alu and L1 polymerase chain reaction probes for rapid characterization of human chromosomes in hybrid cell lines. Proc. Natl Acad. Sci. USA 87, 6634-6638 (1990).
43. Boyle A, Lichter P, Ward DC. Rapid analysis of mouse-hamster hybrid cell lines by in situ hybridization. Genomics 7, 127-130 (1990).
44. Doucette-Stamm LA, Riba L, Handelin B et al. Generation and characterization of irradiation hybrids of human chromosome 4. Somat. Cell. Mol. Genet. 17, 471-480 (1991).
45. Trask BJ, van den Engh G, Christensen M et al. Characterization of somatic cell hybrids by bivariate flow karyotyping and fluorescence in situ hybridization. Somat. Cell. Mol. Genet. 17(2), 117-136 (1991).
46. Nederlof PM, van der Flier S, Wiegant J et al. Multiple fluorescence in situ hybridization. Cytometry 11, 126-131 (1990).
47. Ghadimi BM, Uhr J, Tucker T et al. Interphase cytogenetics with DNA-probes for chromosome 8 to detect circulating tumor cells in breast cancer patients. Zentralbl. Chir. 126(11), 922-925 (2001).
48. Heselmeyer-Haddad K, Chaudhri N, Stoltzfus P et al. Detection of chromosomal aneuploidies and gene copy number changes in fine needle aspirates is a specific, sensitive, and objective genetic test for the diagnosis of breast cancer. Cancer Res. 62(8), 2365-2369 (2002).
49. Poddighe PJ, Ramaekers FC, Hopman AH. Interphase cytogenetics of tumors. J. Pathol. 166(3), 215-224 (1992).
50. Weber RG, Boström J, Woher M et al. Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression. Proc. Natl Acad. Sci. USA 94, 14719-14724 (1997).
51. Ghadimi BM, Heselmeyer-Haddad K, Auer G, Ried T. Interphase cytogenetics: at the interface of genetics and morphology. Anal. Cell. Pathol. 19(1), 3-6 (1999).
52. Tkachuk DC, Westbrook CA, Andreeff M et al. Detection of bcr-ablfusion in chronic myelogeneous leukemia by in situ hybridization. Science 250, 559-562 (1990).
53. Ried T, Lengauer C, Cremer T et al. Specific metaphase and interphase detection of the breakpoint region in 8q24 of Burkitt lymphoma cells by triple-color fluorescence in situ hybridization. Genes Chromosomes Cancer 4, 69-74 (1992).
54. Zijlmans JM, Martens UM, Poon SS et al. Telomeres in the mouse have large interchromosomal variations in the number of T2AG3 repeats. Proc. Natl Acad. Sci. USA 94(14), 7423-7428 (1997).
55. Macville M, Veldman T, Padilla-Nash H et al. Spectral karyotyping, a 24-color FISH technique for the identification of chromosomal rearrangements. Histochem. Cell. Biol. 108, 299-305 (1997).
56. Knutsen T, Veldman T, Padilla-Nash H et al. Spectral karyotyping: chromosomes in color. Appl. Cytogenet. 23, 26-37 (1997).
57. Garini Y, Macville M, du Manoir S et al. Spectral karyotyping. Bioimaging 4, 65-72 (1996).
58. Telenius H, Pelear AH, Tunnacliffe A et al. Cytogenetic analysis by chromosome painting using DOP-PCR amplified flow sorted chromosomes. Genes Chromosomes Cancer 4, 267-263 (1992).
59. Schröck E, Veldman T, Padilla-Nash H et al. Spectral karyotyping refines Cytogenetic diagnostics of constitutional chromosomal abnormalities. Hum. Genet. 101(3), 255-262 (1997).
60. Coleman AE, Schrock E, Weaver Z et al. Previously hidden chromosome aberrations in T(12;15)-positive BALB/c plasmacytomas uncovered by multicolor spectral karyotyping. Cancer Res. 57(20), 4585-4592 (1997).
61. Veldman T, Vignon C, Schrock E, Rowley JD, Ried T. Hidden chromosome abnormalities in haematological malignancies detected by multicolor spectral karyotyping. Nature Genet. 15(4), 406-410 (1997).
62. Zattara-Cannoni H, Dufour H, Lepidi H et al. Hidden chromosome abnormalities in a primary central nervous system lymphoma detected by multicolor spectral karyotyping. Cancer Genet. Cytogenet. 107(2), 98-101 (1998).
63. Liang JC, Ning Y, Wang RY et al. Spectral karyotypic study of the HL-60 cell line: detection of complex rearrangements involving chromosomes 5, 7, and 16 and delineation of critical region of deletion on 5q31.1. Cancer Genet. Cytogenet. 113(2), 105-109 (1999).
64. Hilgenfeld E, Padilla-Nash H, McNeil N et al. Spectral karyotyping and fluorescence in situ hybridization detect novel chromosomal aberrations, a recurring involvement of chromosome 21 and amplification of the MYC oncogene in acute myeloid leukaemia M2. Br. J. Haematol. 113(2), 305-317 (2001).
65. Cohen N, Betts DR, Trakhtenbrot L et al. Detection of unidentified chromosome abnormalities in human neuroblastoma by spectral karyotyping (SKY). Genes Chromosomes Cancer 31(3), 201-208 (2001).
66. Nordgren A, Schoumans J, Soderhall S, Nordenskjold M, Blennow E. Interphase fluorescence in situ hybridization and spectral karyotyping reveals hidden genetic aberrations in children with acute lymphoblastic leukaemia and a normal banded karyotype. Br. J. Haematol. 114(4), 786-793 (2001).
67. Mrozek K, Heinonen K, Theil KS, Bloomfield CD. Spectral karyotyping in patients with acute myeloid leukemia and a complex karyotype shows hidden aberrations, including recurrent overrepresentation of 21q, 11q, and 22q. Genes Chromosomes Cancer 34(2), 137-153 (2002).
68. Heng HH, Ye CJ, Yang F et al. Analysis of marker or complex chromosomal rearrangements present in pre- and postnatal karyotypes utilizing a combination of G-banding, spectral karyotyping and fluorescence in situ hybridization. Clin. Genet. 63(5), 358-367 (2003).
69. Haddad BR, Schrock E, Meck J et al. Identification of de novo chromosomal markers and derivatives by spectral karyotyping. Hum. Genet. 103(5), 619-625 (1998).
70. Huang B, Ning Y, Lamb AN et al. Identification of an unusual marker chromosome by spectral karyotyping. Am. J. Med. Genet. 80(4), 368-372 (1998).
71. Mrozek K, Iliszko M, Rys J et al. Spectral karyotyping reveals 17;22 fusions in a cytogenetically atypical dermatofibrosarcoma protuberans with a large marker chromosome as a sole abnormality. Genes Chromosomes Cancer 31(2), 182-186 (2001).
72. Ariyama Y, Sakabe T, Shinomiya T et al. Identification of amplified DNA sequences on double minute chromosomes in a leukemic cell line KY821 by means of spectral karyotyping and comparative genomic hybridization. J. Hum. Genet. 43(3), 187-190 (1998).
73. Sait SN, Qadir MU, Conroy JM et al. Double minute chromosomes in acute myeloid leukemia and myelodysplastic syndrome: identification of new amplification regions by fluorescence in situ hybridization and spectral karyotyping. Genes Chromosomes Cancer 34(1), 42-47 (2002).
74. du Manoir S, Speicher MR, Joos S et al. Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization. Hum. Genet. 90, 590-610 (1993).
75. du Manoir S, Schrock E, Bentz M et al. Quantitative analysis of comparative genomic hybridization. Cytometry 19, 27-41 (1995).
76. Piper J, Rutovitz D, Sudar D et al. Computer image analysis of comparative genomic hybridization. Cytometry 19, 10-26 (1995).
77. Difilippantonio MJ, Ried T, McNamara G, Bieber FR. Microscopy and image analysis. In: Current Protocols in Human Genetics. Boyle AL (Ed.) John Wiley & Sons, Inc., NY, USA, 4.4.1-4.4.17 (1999).
78. McNeil N, Montagna C, Difilippantonio MJ, Ried T. Comparative cancer cytogenetics. Atlas Genet. Cytogenet. Oncol. Haematol. (2003)
79. Speicher MR, du Manoir S, Schrock E et al. Molecular cytogenetic analysis of formalin-fixed, paraffin-embedded solid tumors by comparative genomic hybridization after universal DNA-amplification. Hum. Mol. Genet. 2(11), 1907-1914 (1993).
80. Isola J, DeVries S, Chu L, Ghazrini S, Waldman F. Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples. Am. J. Pathol. 145, 1301-1308 (1994).
81. Ried T, Just KE, Holtgreve-Grez H et al. Comparative genomic hybridization of formalin-fixed, paraffin-embedded breast tumors reveals different patterns of chromosomal gains and losses in fibroadenomas and diploid and aneuploid carcinomas. Cancer Res. 55(22), 5415-5423 (1995).
82. Speicher MR, Jauch A, Walt H et al. Correlation of microscopic phenotype with genotype in a formalin-fixed, paraffin-embedded testicular germ cell tumor with universal DNA amplification, comparative genomic hybridization, and interphase cytogenetics. Am. J. Pathol. 146, 1332-1340 (1995).
83. Wiltshire R, Duray P, Bittner M et al. Direct visualization of the clonal progression of primary cutaneous melanoma: application of tissue microdissection and comparative genomic hybridization. Cancer Res. 55, 3954-3957 (1995).
84. Green GA, Schrock E, Veldman T et al. Evolving molecular cytogenetic technologies. In: Medical Cytogenetics. Hon Fong L (Ed.), Marcel Dekker, Inc., NY, USA, 579-589 (2000).
85. Struski S, Doco-Fenzy M, Cornillet-Lefebvre P. Compilation of published comparative genomic hybridization studies. Cancer Genet. Cytogenet. 135(1), 63-90 (2002).
86. Ried T, Petersen I, Holtgreve-Grez H et al. Mapping of multiple DNA gains and losses in primary small cell lung carcinomas by comparative genomic hybridization. Cancer Res. 54(7), 1801-1806 (1994).
87. Petersen I. Comparative genomic hybridization of human lung cancer. Methods Mol. Med. 75, 209-237 (2003).
88. Chujo M, Noguchi T, Miura T et al. Comparative genomic hybridization analysis detected frequent overrepresentation of chromosome 3q in squamous cell carcinoma of the lung. Lung Cancer 38(1), 23-29 (2002).
89. Ubagai T, Matsuura S, Tauchi H, Itou K, Komatsu K. Comparative genomic hybridization analysis suggests a gain of chromosome 7p associated with lymph node metastasis in non-small cell lung cancer. Oncol. Rep. 8(1), 83-88 (2001).
90. Luk C, Tsao MS, Bayani J, Shepherd F, Squire JA Molecular cytogenetic analysis of non-small cell lung carcinoma by spectral karyotyping and comparative genomic hybridization. Cancer Genet. Cytogenet. 125(2), 87-99 (2001).
91. Balsara BR, Sonoda G, du Manoir S et al. Comparative genomic hybridization analysis detects frequent, often high-level, overrepresentation of DNA sequences at 3q, 5p, 7p, and 8q in human non-small cell lung carcinomas. Cancer Res. 57(11), 2116-2120 (1997).
92. Courjal F, Theillet C. Comparative genomic hybridization analysis of breast tumors with predetermined profiles of DNA amplification. Cancer Res. 57, 4368-4377 (1997).
93. Kallioniemi A, Kallioniemi OP, Piper J et al. Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc. Natl Acad. Sci. USA 91(6), 2156-2160 (1994).
94. Kallioniemi OP, Kallioniemi A, Piper J et al. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer 10(4), 231-243 (1994).
95. James LA, Mitchell EL, Menasce L, Varley JM. Comparative genomic hybridisation of ductal carcinoma in situ of the breast: identification of regions of DNA amplification and deletion in common with invasive breast carcinoma. Oncogene 14(9), 1059-1065 (1997).
96. Burki NG, Caduff R, Walt H et al. Comparative genomic hybridization of fine needle aspirates from breast carcinomas. Int. J. Cancer 88(4), 607-613 (2000).
97. Nishizaki T, DeVries S, Chew K et al. Genetic alterations in primary breast cancers and their metastases: direct comparison using modified comparative genomic hybridization. Genes Chromosomes Cancer 19(4), 267-272 (1997).
98. Tsushimi T, Noshima S, Oga A, Esato K, Sasaki K. DNA amplification and chromosomal translocations are accompanied by chromosomal instability: analysis of seven human colon cancer cell lines by comparative genomic hybridization and spectral karyotyping. Cancer Genet. Cytogenet. 126(1), 34-38 (2001).
99. Schlegel J, Stumm G, Scherthan H et al. Comparative genomic in situ hybridization of colon carcinomas with replication error. Cancer Res. 55(24), 6002-6005 (1995).
100. Masramon L, Ribas M, Cifuentes P et al. Cytogenetic characterization of two colon cell lines by using conventional G-banding, comparative genomic hybridization, and whole chromosome painting. Cancer Genet. Cytogenet. 121(1), 17-21 (2000).
101. Ried T, Knutzen R, Steinbeck R et al. Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors. Genes Chromosomes Cancer 15(4), 234-245 (1996).
102. Aust DE, Willenbucher RF, Terdiman JP et al. Chromosomal alterations in ulcerative colitis-related and sporadic colorectal cancers by comparative genomic hybridization. Hum. Pathol. 31(1), 109-114 (2000).
103. Ghadimi BM, Sackett DL, Difilippantonio MJ et al. Centrosome amplification and instability occurs exclusively in aneuploid, but not in diploid colorectal cancer cell lines, and correlates with numerical chromosomal aberrations. Genes Chromosomes Cancer 27(2), 183-190 (2000).
104. Giollant M, Bertrand S, Verrelle P et al. Characterization of double minute chromosomes' DNA content in a human high grade astrocytoma cell line by using comparative genomic hybridization and fluorescence in situ hybridization. Hum. Genet. 98(3), 265-270 (1996).
105. Schröck E, Blume C, Meffert MC et al. Recurrent gain of chromosome arm 7q in low-grade astrocytic tumors studied by comparative genomic hybridization. Genes Chromosomes Cancer 15(4), 199-205 (1996).
106. Mohapatra G, Kim DH, Feuerstein BG. Detection of multiple gains and losses of genetic material in ten glioma cell lines by comparative genomic hybridization. Genes Chromosomes Cancer 13(2), 86-93 (1995).
107. Shlomit R, Ayala AG, Michal D et al. Gains and losses of DNA sequences in childhood brain tumors analyzed by comparative genomic hybridization. Cancer Genet. Cytogenet. 121(1), 67-72 (2000).
108. Cher ML, MacGrogan D, Bookstein R et al. Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer. Genes Chromosomes Cancer 11(3), 153-162 (1994).
109. Joos S, Bergerheim US, Pan Y et al. Mapping of chromosomal gains and losses in prostate cancer by comparative genomic hybridization. Genes Chromosomes Cancer 14(4), 267-276 (1995).
110. Visakorpi T, Kallioniemi AH, Syvanen AC et al. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res. 55(2), 342-347 (1995).
111. Sattler HP, Rohde V, Bonkhoff H, Zwergel T, Wullich B. Comparative genomic hybridization reveals DNA copy number gains to frequently occur in human prostate cancer. Prostate 39(2), 79-86 (1999).
112. Kim SH, Kim MS, Jensen RH. Genetic alterations in microdissected prostate cancer cells by comparative genomic hybridization. Prostate Cancer Prostatic Dis. 3(2), 110-114 (2000).
113. Rokman A, Koivisto PA, Matikainen MP et al. Genetic changes in familial prostate cancer by comparative genomic hybridization. Prostate 46(3), 233-239 (2001).
114. Speicher MR, Howe C, Crotty P et al. Comparative genomic hybridization detects novel deletions and amplifications in head and neck squamous cell carcinomas. Cancer Res. 55(5), 1010-1013 (1995).
115. Bergamo NA, Rogatto SR, Poli-Frederico RC et al. Comparative genomic hybridization analysis detects frequent over-representation of DNA sequences at 3q, 7p, and 8q in head and neck carcinomas. Cancer Genet. Cytogenet. 119(1), 48-55 (2000).
116. Hashimoto Y, Oga A, Okami K et al. Relationship between cytogenetic aberrations by CGH coupled with tissue microdissection and DNA ploidy by laser scanning cytometry in head and neck squamous cell carcinoma. Cytometry 40(2), 161-166 (2000).
117. Huang Q, Yu GP, McCormick SA et al. Genetic differences detected by comparative genomic hybridization in head and neck squamous cell carcinomas from different tumor sites: construction of oncogenetic trees for tumor progression. Genes Chromosomes Cancer 54(2), 224-233 (2002).
118. Squire JA, Bayani J, Luk C et al. Molecular cytogenetic analysis of head and neck squamous cell carcinoma: by comparative genomic hybridization, spectral karyotyping, and expression array analysis. Head Neck 24(9), 874-887 (2002).
119. Tremmel SC, Gotte K, Popp S et al. Intratumoral genomic heterogeneity in advanced head and neck cancer detected by comparative genomic hybridization. Cancer Genet. Cytogenet. 144(2), 165-174 (2003).
120. Wilkens L, Tchinda J, Burkhardt D et al. Analysis of hematologic diseases using conventional karyotyping, fluorescence in situ hybridization (FISH), and comparative genomic hybridization (CGH). Hum. Pathol. 29(8), 833-839 (1998).
121. Bentz M, Dohner H, Werner CA et al. Identification of genetic imbalances in malignant lymphoma using comparative genomic hybridization. Stem Cells 13(Suppl. 3), 83-87 (1995).
122. Mathew S, Raimondi SC. FISH, CGH, and SKY in the diagnosis of childhood acute lymphoblastic leukemia. Methods Mol. Biol. 220, 213-233 (2003).
123. Zitzelsberger H, Lehmann L, Werner M, Bauchinger M. Comparative genomic hybridization for the analysis of chromosomal imbalances in solid tumors and haematological malignancies. Histochem. Cell. Biol. 108(4-5), 403-417 (1997).
124. Speicher MR, Schoell B, du Manoir S et al. Specific loss of chromosomes 1, 2, 6, 10, 13, 17, and 21 in chromophobe renal cell carcinomas revealed by comparative genomic hybridization. Am. J. Pathol. 145(2), 356-364 (1994).
125. Jiang F, Moch H, Richter J et al. Comparative genomic hybridization reveals frequent chromosome 13q and 4q losses in renal carcinomas with sarcomatoid transformation. J. Pathol. 185(4), 382-388 (1998).
126. Barnard M, Bayani J, Grant R et al. Comparative genomic hybridization analysis of clear cell sarcoma of the kidney. Med. Pediatr. Oncol. 34(2), 113-116 (2000).
127. Junker K, Moravek P, Podhola M et al. Genetic alterations in metastatic renal cell carcinoma detected by comparative genomic hybridization: correlation with clinical and histological data. Int. J. Oncol. 17(5), 903-908 (2000).
128. Reutzel D, Mende M, Naumann S et al. Genomic imbalances in 61 renal cancers from the proximal tubulus detected by comparative genomic hybridization. Cytogenet. Cell Genet. 93(3-4), 221-227 (2001).
129. Pavlovich CP, Padilla-Nash H, Wangsa D et al. Patterns of aneuploidy in stage IV clear cell renal cell carcinoma revealed by comparative genomic hybridization and spectral katyotyping. Genes Chromosomes Cancer 37(3), 252-260 (2003).
130. Rigola MA, Casadevall C, Bernues M et al. Analysis of kidney tumors by comparative genomic hybridization and conventional cytogenetics. Cancer Genet. Cytogenet. 137(1), 49-53 (2002).
131. Sonoda G, Palazzo J, du Manoir S et al. Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomas. Genes Chromosomes Cancer 20(4), 320-328 (1997).
132. Tapper J, Sarantaus L, Vahteristo P et al. Genetic changes in inherited and sporadic ovarian carcinomas by comparative genomic hybridization: extensive similarity except for a difference at chromosome 2q24-q32. Cancer Res. 58(13), 2715-2719 (1998).
133. Staebler A, Heselmeyer-Haddad K, Bell K et al. Micropapillary serous carcinoma of the ovary has distinct patterns of chromosomal imbalances by comparative genomic hybridization compared with atypical proliferative serous tumors and serous carcinomas. Hum. Pathol. 33(1), 47-59 (2002).
134. Jacobsen A, Arnold N, Weimer J, Kiechle M. Comparison of comparative genomic hybridization and interphase fluorescence in situ hybridization in ovarian carcinomas: possibilities and limitations of both techniques. Cancer Genet. Cytogenet. 122(1), 7-12 (2000).
135. Kiechle M, Jacobsen A, Schwarz-Boeger U et al. Comparative genomic hybridization detects genetic imbalances in primary ovarian carcinomas as correlated with grade of differentiation. Cancer 91(3), 534-540 (2001).
136. Hu J, Khanna V, Jones MW, Surti U. Comparative study of primary and recurrent ovarian serous carcinomas: comparative genomic hybridization analysis with a potential application for prognosis. Gynecol. Oncol. 89(3), 369-375 (2003).
137. Kallioniemi A, Kallioniemi O-P, Citro G et al. Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization. Genes Chromosom. Cancer 12, 213-219 (1995).
138. Voorter C, Joos S, Bringuier PP et al. Detection of chromosomal imbalances in transitional cell carcinoma of the bladder by comparative genomic hybridization. Am. J. Pathol. 146, 1341-1354 (1995).
139. Richter J, Beffa L, Wagner U et al. Patterns of chromosomal imbalances in advanced urinary bladder cancer detected by comparative genomic hybridization. Am. J. Pathol. 153(5), 1615-1621 (1998).
140. Koo SH, Kwon KC, Ihm CH et al. Detection of genetic alterations in bladder tumors by comparative genomic hybridization and cytogenetic analysis. Cancer Genet. Cytogenet. 110(2), 87-93 (1999).
141. Prat E, Bernues M, Caballin MR et al. Detection of chromosomal imbalances in papillary bladder tumors by comparative genomic hybridization. Urology 57(5), 986-992 (2001).
142. Fadl-Elmula I, Kytola S, Leithy ME et al. Chromosomal aberrations in benign and malignant bilharzia-associated bladder lesions analyzed by comparative genomic hybridization. BMC Cancer 2(1), 5 (2002).
143. Heselmeyer K, Schrock E, du Manoir S et al. Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc. Natl Acad. Sci. USA 93(1), 479-484 (1996).
144. Packenham JP, du Manoir S, Schrock E et al. Analysis of genetic alterations in uterine leiomyomas and leiomyosarcomas by comparative genomic hybridization. Mol. Carcinog. 19(4), 273-279 (1997).
145. Kirchhoff M, Rose H, Petersen BL et al. Comparative genomic hybridization reveals a recurrent pattern of chromosomal aberrations in severe dysplasia/carcinoma in situ of the cervix and in advanced-stage cervical carcinoma. Genes Chromosomes Cancer 24(2), 144-150 (1999).
146. Allen DG, White DJ, Hutchins AM et al. Progressive genetic aberrations detected by comparative genomic hybridization in squamous cell cervical cancer. Br. J. Cancer 83(12), 1659-1663 (2000).
147. Kirchhoff M, Rose H, Petersen BL et al. Comparative genomic hybridization reveals non-random chromosomal aberrations in early preinvasive cervical lesions. Cancer Genet. Cytogenet. 129(1), 47-51 (2001).
148. Umayahara K, Numa F, Suehiro Y et al. Comparative genomic hybridization detects genetic alterations during early stages of cervical cancer progression. Genes Chromosomes Cancer 33(1), 98-102 (2002).
149. Schröck E, Thiel G, Lozanova T et al. Comparative genomic hybridization of human glioma reveals consistent genetic imbalances and multiple amplification sites. Am. J. Pathol. 144, 1203-1218 (1994).
150. Kim DH, Mohapatra G, Bollen A, Waldman FM, Feuerstein BG. Chromosomal abnormalities in glioblastoma multiforme tumors and glioma cell lines detected by comparative genomic hybridization. Int. J. Cancer 60(6), 812-819 (1995).
151. Schlegel J, Scherthan H, Arens N, Stumm G, Kiessling M. Detection of complex genetic alterations in human glioblastoma multiforme using comparative genomic hybridization. J. Neuropathol. Exp. Neurol. 55(1), 81-87 (1996).
152. Montagna C, Lyu MS, Hunter K et al. The Septin 9 (MSF) gene is amplified and overexpressed in mouse mammary gland adenocarcinomas and human breast cancer cell lines. Cancer Res. 63(9), 2179-2187 (2003).
153. Parente F, Gaudray P, Carle GF, Turc-Carel C. Experimental assessment of the detection limit of genomic amplification by comparative genomic hybridization CGH. Cytogenet. Cell Genet. 78(1), 65-68 (1997).
154. Verhagen PC, Zhu XL, Rohr LR et al. Microdissection, DOP-PCR, and comparative genomic hybridization of paraffin-embedded familial prostate cancers. Cancer Genet. Cytogenet. 122(1), 43-48 (2000).
155. Zweemer RP, Ryan A, Snijders AM et al. Comparative genomic hybridization of microdissected familial ovarian carcinoma: two deleted regions on chromosome 15q not previously identified in sporadic ovarian carcinoma. Lab. Invest. 81(10), 1363-1370 (2001).
156. Beheshti B, Vukovic B, Marrano P, Squire JA, Park PC. Resolution of genotypic heterogeneity in prostate tumors using polymerase chain reaction and comparative genomic hybridization on microdissected carcinoma and prostatic intraepithelial neoplasia foci. Cancer Genet. Cytogenet. 137(1), 15-22 (2002).
157. Alcock HE, Stephenson TJ, Royds JA, Hammond DW. Analysis of colorectal tumor progression by microdissection and comparative genomic hybridization. Genes Chromosomes Cancer 37(4), 369-380 (2003).
158. Blegen H, Ghadimi BM, Jauho A et al. Genetic instability promotes the acquisition of chromosomal imbalances in T1b and T1c breast adenocarcinomas. Anal. Cell. Pathol. 22(3), 123-131 (2001).
159. Hauptmann S, Denkert C, Koch I et al. Genetic alterations in epithelial ovarian tumors analyzed by comparative genomic hybridization. Hum. Pathol. 33(6), 632-641 (2002).
160. Solinas-Toldo S, Lampel S, Stilgenbauer S et al. Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances. Genes Chromosomes Cancer 20(4), 399-407 (1997).
161. Albertson DG, Ylstra B, Segraves R et al. Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nature Genet. 25(2), 144-146 (2000).
162. Ishkanian AS, Malloff CA, Watson SK et al. A tiling resolution DNA microarray with complete coverage of the human genome. Nature Genet. 36(3), 299-303 (2004).